Jade Biosciences, Inc.
Status: Publicly traded
Direct answer
Jade Biosciences, Inc. is publicly traded on NASDAQ under the ticker JBIO.
Jade Biosciences, Inc. operates as a biotechnology enterprise, primarily focused on pioneering superior therapeutic solutions for significant unmet medical requirements in autoimmune disorders. Its leading development candidate, JADE-001, specifically targets the anti-A PRoliferation-Inducing Ligand (APRIL) pathway, aiming to treat immunoglobulin A (IgA) nephropathy. Clinical trials for JADE-001 are slated to...
Can you invest in Jade Biosciences, Inc.?
Yes. Jade Biosciences, Inc. trades publicly on NASDAQ as JBIO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jade Biosciences, Inc.
Detailed equity research is provided by MarketSnap.